Association of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
CONCLUSIONS.—: PDACs with different mutant KRAS alleles are associated with distinct morphologies and clinical outcomes, with KRAS G12R allele associated with P+LD morphology and longer OS when compared with G12D using Kaplan-Meier studies.PMID:38452805 | DOI:10.5858/arpa.2023-0005-OA
Source: Archives of Pathology and Laboratory Medicine - Category: Laboratory Medicine Authors: Timothy Chao Zi-Xuan Wang Wilbur B Bowne Clifford J Yudkoff Ava Torjani Vishal Swaminathan Taylor R Kavanagh Austin Roadarmel Cyrus J Sholevar Shawnna Cannaday Geoffrey Krampitz Tingting Zhan Eliyahu Gorgov Avinoam Nevler Harish Lavu Charles J Yeo Stephen Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Genetics | Laboratory Medicine | Mucinous Carcinoma | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Pathology | Study | Undifferentiated Carcinoma